ExozymesEXOZ
13F holders, Q4 2024 (December 31)7holders
1famous investor
$16.50avg. 13F price*
At the end of Q4 2024, 7 institutions reported holding Exozymes Inc. (EXOZ) in their 13F filings. The largest holders were Vanguard Group Inc. ($833K), Citadel Advisors ($456K) and Geode Capital Management, LLC ($277K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Exozymes Inc.
- Filed as
- INVIZYNE TECHNOLOGIES INC (Q4 2024)
- CUSIP
- 461874109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $1.6M |
| Exits | 0 | $0 |
Ownership 7 holders
| Vanguard Group Inc. | 0.00% | New | 50,460 | $833K |
| Citadel Advisors | 0.00% | New | 27,652 | $456K |
| Geode Capital Management, LLC | 0.00% | New | 16,764 | $277K |
| BNP Paribas Financial Markets | 0.00% | New | 2,113 | $35K |
| UBS Group AG | 0.00% | New | 707 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 389 | $6K |
| Bank of America Corp. | 0.00% | New | 15 | $248 |
"% of holder's portfolio" is EXOZ's weight in each manager's 13F, not the share of Exozymes Inc. the manager owns.